CNXU · Conexeu Sciences Inc.
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of these unaudited condensed interim financial statements being issued. The ability of the Company to continue as a going concern is dependent upon the Company's ability to raise additional funds and implement its business plan. These unaudited condensed interim financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Such adjustments could be material.”View the 10-Q filed Jun 15, 2026
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
CNXU Latest Reported Short Interest
FINRA reported 129,461 CNXU shares sold short as of the August 14, 2026 settlement date, a decrease of 18,321 shares. Days to cover was 1.00 based on FINRA's reported average daily volume.
Official FINRA short-interest data · share counts are restated for subsequent splits of this listing
CNXU Short Interest Forecast
Equibles' model estimates 173,714 shares sold short for the August 31, 2026 settlement, +34.2% versus the latest reported position, with a likely range of 108,855 to 290,807 shares. This model prediction uses FINRA data through August 31, 2026; FINRA's official release is expected September 10, 2026.
Expected Aug 31 short interest
as of Aug 31 High confidence 81% chance it risesPositioning score 28.2 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.
Method and coverage limits
Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-08-14). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.
Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.
The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.
Options positioning & squeeze sensitivity
Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.
No active listed options were found.
Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.
Assessment prepared 2026-09-07 03:18 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-09-15
Scheduled
FINRA publishes Sep 24
|
— | — | — | — |
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
| 2026-08-14 | 129,461 | 147,782 | -18,321 | 1.00 |
| 2026-07-31 | 147,782 | 170,673 | -22,891 | 1.26 |
| 2026-07-15 | 170,673 | 37,335 | +133,338 | 1.09 |
| 2026-06-30 | 37,335 | 25,544 | +11,791 | 1.00 |
| 2026-06-15 | 25,544 | 21,639 | +3,905 | 1.00 |
| 2026-05-29 | 21,639 | 0 | +21,639 | 1.00 |
Full FINRA short interest reporting calendar